Clinical spectrum of X-linked hyper-IgM syndrome
- 1 July 1997
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 131 (1), 47-54
- https://doi.org/10.1016/s0022-3476(97)70123-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndromeImmunology Today, 1996
- A central role of CD40 ligand in the regulation of CD4+ T-cell responsesImmunology Today, 1996
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis InfectionImmunity, 1996
- Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interactionEuropean Journal of Immunology, 1995
- AIDS-related cholangitis: Diagnostic features and course in 15 patientsJournal of Hepatology, 1993
- CD40 ligand is a T cell growth factorEuropean Journal of Immunology, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Evidence for a Defect in Switch T Cells in Patients with Immunodeficiency and Hyperimmunoglobulinemia MThe New England Journal of Medicine, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958